TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive NCI Program Review: Report calls For Two Types Of Centers: Comprehensive And All Others October 18, 1996
TCL Archive Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear April 18, 2014
